3 Results for "

ELOVL1-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ELOVL1-IN-3" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-145272
CAS No.: 2761063-99-2
Purity:  99.81%
Target:  

ELOVL

Research Areas:  

Neurological Disease

ELOVL1-IN-3 (Compound 22) is a potent and orally active inhibitor of elongation of very long chain fatty acid 1 (ELOVL1) enzyme. ELOVL1-IN-3 serves as a useful tool for researching adrenoleukodystrophy (ALD) [1].
loading...
    loading...
Cat. No.: HY-152947
CAS No.: 1170321-92-2
Purity:  98.63%
Target:  

ELOVL

Research Areas:  

Metabolic Disease

ELOVL6-IN-4 is a potent, selective, and orally active long chain fatty acid elongase 6 (ELOVL6) inhibitor with IC50s of 79 nM and 94 nM for human and mouse ELOVL6, respectively. ELOVL6-IN-4 shows excellent selectivity over the other human ELOVL subtypes (ELOVL1, -2, -3, and -5) and mouse ELOVL3 .
loading...
    loading...
Cat. No.: HY-160912
CAS No.: 1135000-36-0
Target:  

ELOVL

Research Areas:  

Metabolic Disease

ELOVL6-IN-5 is an orally active and selective elongase enzyme of long-chain fatty acid family 6 (ELOVL6) inhibitor with IC50 values of 85 nM and 38 nM for human and mouse ELOVL6, respectively. ELOVL6-IN-5 shows >60-fold selectivity over other ELOVL family enzymes (ELOVL1, 2, 3, 5) and no effect on other lipid synthesis enzymes like ACC1, ACC2. ELOVL6-IN-5 reduces hepatic fatty acid composition ratio of C18 to C16 in diet-induced obesity (DIO) and KKAy mice. ELOVL6 inhibition by ELOVL6-IN-5 does not improve insulin resistance. ELOVL6-IN-5 can be used for the research of metabolic disease .
loading...
    loading...